REPLIGEN CORPORATION - COMMON STOCK
158.99
21-فبراير-25 16:45:00
15 متأخرة بدقائق
الأسهم
-3.68
-2.26%
نطاق اليوم
156.18 - 165.00
ISIN
N/A
المصدر
NASDAQ
-
Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum
14 مارس 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Repligen Reports Fourth Quarter and Full Year 2022 Financial Results
22 فبراير 2023 07:30:01 بحسب Nasdaq GlobeNewswire
-
Repligen Appoints Martin D. Madaus to Board of Directors
09 فبراير 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Repligen to Report Fourth Quarter and Full Year 2022 Financial Results
08 فبراير 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Repligen Corporation to Present at 41st Annual J.P. Morgan Healthcare Conference
03 يناير 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Repligen Corporation to Present at Upcoming Investor Conferences
08 نوفمبر 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Repligen Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance
01 نوفمبر 2022 07:30:01 بحسب Nasdaq GlobeNewswire
-
Repligen Extends and Expands Long-Term Supply Agreement with Purolite for Affinity Ligands
01 نوفمبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
Repligen to Report Third Quarter 2022 Financial Results
12 أكتوبر 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Repligen Expands Process Analytics Portfolio with DRS Daylight Solutions Agreement
19 سبتمبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire
-
Repligen To Host Investor Day 2022
24 أغسطس 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Repligen Reports Second Quarter 2022 Financial Results and Raises Full Year 2022 Financial Guidance
02 أغسطس 2022 07:30:01 بحسب Nasdaq GlobeNewswire
-
Repligen to Report Second Quarter 2022 Financial Results
19 يوليو 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors
26 مايو 2022 16:30:00 بحسب Nasdaq GlobeNewswire
-
Repligen Corporation to Present at Upcoming Investor Conferences
25 مايو 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Repligen Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance
27 أبريل 2022 07:30:01 بحسب Nasdaq GlobeNewswire
-
Repligen to Report First Quarter 2022 Financial Results
13 أبريل 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum
18 مارس 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Repligen Reports Fourth Quarter and Full Year 2021 Financial Results
17 فبراير 2022 07:30:01 بحسب Nasdaq GlobeNewswire
-
Repligen Launches AAV Affinity Resins for Gene Therapy Purification
15 فبراير 2022 07:30:00 بحسب Nasdaq GlobeNewswire